NasdaqGM - Nasdaq Real Time Price USD

Vanda Pharmaceuticals Inc. (VNDA)

4.4400
+0.1300
+(3.02%)
At close: May 20 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
201,351
198,772
192,640
254,382
268,682
Cost of Revenue
11,395
11,314
14,796
24,282
25,629
Gross Profit
189,956
187,458
177,844
230,100
243,053
Operating Expense
262,409
228,118
191,796
223,771
200,888
Operating Income
-72,453
-40,660
-13,952
6,329
42,165
Other Income Expense
16,828
17,739
20,291
4,971
199
Pretax Income
-55,625
-22,921
6,339
11,300
42,364
Tax Provision
-11,377
-4,021
3,830
5,025
9,212
Net Income Common Stockholders
-44,248
-18,900
2,509
6,275
33,152
Diluted NI Available to Com Stockholders
-44,248
-18,900
2,509
6,275
33,152
Basic EPS
-0.76
-0.33
0.04
0.11
0.60
Diluted EPS
-0.76
-0.33
0.04
0.11
0.58
Basic Average Shares
58,340.7960
58,149.0870
57,380.9750
56,461.8770
55,548.1220
Diluted Average Shares
58,340.7960
58,149.0870
57,557.9110
56,983.1710
56,921.8360
Total Operating Income as Reported
-72,453
-40,660
-13,952
6,329
42,165
Total Expenses
273,804
239,432
206,592
248,053
226,517
Net Income from Continuing & Discontinued Operation
-44,248
-18,900
2,509
6,275
33,152
Normalized Income
-44,248
-18,900
2,509
6,275
33,152
EBIT
-72,453
-40,660
-13,952
6,329
42,165
EBITDA
-64,562
-32,528
-10,942
9,062
45,006
Reconciled Cost of Revenue
10,511
10,455
13,876
23,065
24,266
Reconciled Depreciation
7,891
8,132
3,010
2,733
2,841
Net Income from Continuing Operation Net Minority Interest
-44,248
-18,900
2,509
6,275
33,152
Normalized EBITDA
-64,562
-32,528
-10,942
9,062
45,006
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/12/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GRCE Grace Therapeutics, Inc.
2.9675
-1.08%
 
RIGL Rigel Pharmaceuticals, Inc.
20.12
+2.13%
 
PYPD PolyPid Ltd.
2.9000
+3.20%
 
CADL Candel Therapeutics, Inc.
5.91
+3.68%
 
MIST Milestone Pharmaceuticals Inc.
1.3900
+7.75%
 
IOVA Iovance Biotherapeutics, Inc.
1.9100
+4.37%
 
AVXL Anavex Life Sciences Corp.
7.53
-10.78%
 
FOLD Amicus Therapeutics, Inc.
6.59
+2.65%
 
ANNX Annexon, Inc.
2.1000
+0.48%
 
CHRS Coherus BioSciences, Inc.
0.8161
+2.01%